Showing 581-590 of 2875 results for "".
- BOTOX Cosmetic Names 2026 Confidence Collective Entrepreneur Cohorthttps://modernaesthetics.com/news/botox-cosmetic-names-2026-confidence-collective-entrepreneur-cohort/2487577/Allergan Aesthetics, an AbbVie company, has announced the 2026 cohort for The Confidence Collective: Empowering Women Entrepreneurs, a BOTOX® Cosmetic initiative designed to support women business owners through mentorship, education, and funding opportunities. According to the company, th
- Platelet-Rich Plasma May Function as a Bioregulatory System in Soft-Tissue Remodelinghttps://modernaesthetics.com/news/platelet-rich-plasma-may-function-as-a-bioregulatory-system-in-soft-tissue-remodeling/2487555/A newly published review in Aesthetic Plastic Surgery examines the evolving understanding of platelet-rich plasma (PRP), suggesting that its role in soft-tissue repair extends beyond conventional growth-factor delivery and may involve broader regulation of the tissue microenvironment.
- RRS® HA LONG LASTING Earns Top Skin Revitalization Honor at AMWC 2026https://modernaesthetics.com/news/rrs-ha-long-lasting-earns-top-skin-revitalization-honor-at-amwc-2026/2487529/Skin Tech Pharma Group announced that RRS® HA LONG LASTING has been awarded Best Injectable in the Skin Revitalization category at the AMWC Aesthetic Medicine Awards 2026, a recognition presented during the Aesthetic & Anti-Aging Medicine World Congress (AMWC). The award recognizes RRS
- Cellese Appoints Christopher Hausman as CEO to Lead Next Phase of Growth in Regenerative Aestheticshttps://modernaesthetics.com/news/cellese-appoints-christopher-hausman-as-ceo-to-lead-next-phase-of-growth-in-regenerative-aesthetics/2487520/Cellese Inc., the regenerative aesthetics company behind the AnteAGE® skincare brand, has appointed Christopher Hausman as Chief Executive Officer, the company announced. Hausman joins Irvine, California-based Cellese with more than 3 decades of experience in the aesthetics, skincare, dent
- FDA Approves SKINVIVE by JUVÉDERM® for Treatment of Horizontal Neck Lineshttps://modernaesthetics.com/news/fda-approves-skinvive-by-juvederm-for-treatment-of-horizontal-neck-lines/2487508/The US Food and Drug Administration (FDA) has approved SKINVIVE by JUVÉDERM® (Allergan Aesthetics, an AbbVie company) for the reduction of neck lines and improvement of neck appearance in adults aged 21 years and older, according to an announcement from the company. With the approval, SKIN
- Induction Therapies Launches Recovery Serum for At-Home Skincare Supporthttps://modernaesthetics.com/news/induction-therapies-launches-recovery-serum-for-at-home-skincare-support/2487505/Induction Therapies has introduced YouthXO + PDRN, a new recovery and renewal serum designed to support skin health between professional aesthetic treatments and as part of a daily skincare regimen. According to the company, the serum combines plant exosomes, vegan polydeoxyribonucleotide
- FDA Approves Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel for Midface Augmentationhttps://modernaesthetics.com/news/fda-approves-obagi-saypha-chiq-injectable-hyaluronic-acid-gel-for-midface-augmentation/2487470/Waldencast plc announced that the US Food and Drug Administration (FDA) has approved Obagi® saypha® ChIQ™ injectable hyaluronic acid (HA) gel, expanding the Obagi Medical injectable portfolio and strengthening the company’s position within the medical aesthetics market. According to the co
- New Anatomy-Based Framework Targets Prevention of GLP-1 RA-Associated Facial Aginghttps://modernaesthetics.com/news/new-anatomy-based-framework-targets-prevention-of-glp-1-ra-associated-facial-aging/2487408/A conceptual model published online ahead of print in Aesthetic Plastic Surgery proposes an anatomy-driven approach to identifying and preventing facial aging changes associated with glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, commonly referred to as “Ozempic face.”
- Review Examines Glycation’s Expanding Role in Cutaneous Aginghttps://modernaesthetics.com/news/review-examines-glycations-expanding-role-in-cutaneous-aging/2487357/A narrative review published in the Journal of Cosmetic Dermatology examines the growing evidence linking glycation and advanced glycation end products (AGEs) to skin aging, highlighting potential implications for both dermatology and aesthetic medicine. In the review, Diala Hayka
- Simultaneous Skin Pinch Blepharoplasty, Full-Field Er:YAG Resurfacing Shows Favorable Outcomes for Lower Eyelid Rejuvenationhttps://modernaesthetics.com/news/simultaneous-skin-pinch-blepharoplasty-full-field-eryag-resurfacing-shows-favorable-outcomes-for-lower-eyelid-rejuvenation/2487318/A combined approach incorporating lower eyelid skin pinch blepharoplasty and full-field erbium:YAG laser resurfacing demonstrated favorable aesthetic outcomes with a low complication rate in a retrospective case series published online ahead of print in the Journal of Cosmetic and Laser Thera